Investment
Features
FeesSafety
Academy
More
Pluang+

Compare International Business Machines Corp (IBM) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

International Business Machines CorpTrade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

International Business Machines Corp vs Vaxcyte Inc. Common Stock — how do they compare? International Business Machines Corp trades at $228.77 (market cap $217.43B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: International Business Machines Corp is far larger — about 20.7× Vaxcyte Inc. Common Stock's market cap, and International Business Machines Corp pays a 2.93% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 89 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

IBMPCVX
Market Cap
$217.43B$10.51B
Volume
5,119,4862,644,694
Sector
TechnologyHealth
52-Week High
$329.23$73.82
52-Week Low
$205.77$40.32
Typical Hold Time
89 Days0 Days
Enterprise Value
$274.57B$9.14B
Dividend Yield
2.93%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

International Business Machines Corp

IBM trades at $227.88, up 0.38% with a bearish technical signal despite recent positive momentum. The company shows strong fundamentals with 2025 revenue of $67.54B and net income of $10.59B, representing a 15.52% margin. Recent earnings beat expectations in two of the last three quarters, while Q3 2026 results are pending. Analyst consensus is mixed with 47% buy ratings and a $255.50 price target, suggesting 12% upside potential from current levels.

IBM presents a balanced opportunity with solid profitability and AI consulting growth offset by cyclical mainframe weakness and negative cash flow trends. The stock's current valuation at 20.5x P/E appears reasonable given the company's pivot to high-margin hybrid cloud and AI services. Key risks include execution challenges in the AI transition and competitive pressures in the consulting space.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IBM
13% Buy87% Sell
Avg holding period · 89 Days
PCVX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.

Read more on IBM →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →